📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here? (2022)

First Author: Peters R

Attributed to: MICA: Dementias Platform UK 2 - Integrated Dementia Experimental Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/alz.12393

PubMed Identifier: 34726352

Publication URI: http://europepmc.org/abstract/MED/34726352

Type: Journal Article/Review

Volume: 18

Parent Publication: Alzheimer's & dementia : the journal of the Alzheimer's Association

Issue: 3

ISSN: 1552-5260